Clinical Trials Browser

Enrolling by invitation × Nivolumab × 1 year × Clear all

NCT07542262 2026-04-21

NIVO402025

Phase 2 Enrolling by invitation

Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT06896110 2025-06-26

Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma

Phase 1 Enrolling by invitation

Astrocytoma, Glioblastoma